ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665759 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665759; 2) Community: the network communities that were significantly associated with the response to NSC 665759; 3) Molecule: the relationships between components within communities and NSC 665759; 4) MDR: the compounds that were significantly associated with the NSC 665759.

NSC Compound Enrichment Correlation
NSC 687011 stereoisomer of 672120 (MW=262) 0.0388857481216096 0.062715996
NSC 702045 2-Propenone, 1,1'-(2,5-pyridinediyl)bis[3-(3,4-dimethoxyphenyl)- 0.0388857481216096 0.017656743
NSC 710904 Null 0.0388857481216096 -0.05427393
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0388857481216096 0.084613995
NSC 101003 Null 0.03888574812161 0.02315236
NSC 174121 Methotrexate Derivative 0.03888574812161 0.1104399
NSC 181500 Null 0.03888574812161 -0.054557495
NSC 191924 Null 0.03888574812161 0.014763997
NSC 271674 Carboxyphthalatoplatinum 0.03888574812161 0.15485298
NSC 272346 1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride 0.03888574812161 0.074387043
Total:95  Current:71    [First] [Prev] [Next] [Last]